Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.53	56.75	32.79	24.46	18.89	30.37
Short-Term Investments	88.61	20.58	24.15	33.75	106.08	26.95
Cash & Short-Term Investments	137.14	77.32	56.93	58.21	124.97	57.33
Cash Growth	124.41%	35.81%	-2.19%	-53.42%	117.99%	-41.55%
Receivables	45.93	41.62	30.55	40.32	15.47	15.97
Inventory	20.61	9.8	5.52	17.38	6.62	5.64
Prepaid Expenses	5.39	6.37	6.26	-	7.41	10.05
Total Current Assets	214.93	135.1	99.27	115.9	154.47	88.98
Property, Plant & Equipment	1.1	0.34	1.03	2.79	11.89	20.57
Other Intangible Assets	25.34	27.1	13.88	14.95	-	-
Other Long-Term Assets	1.17	1.44	3.06	0.64	0.97	0.82
Total Assets	242.53	163.98	117.23	134.28	167.33	110.38
Accounts Payable	3.85	3.34	7.14	22.51	3.8	3.71
Accrued Expenses	48.98	46.33	29.28	31.91	31.75	24.01
Current Portion of Long-Term Debt	29.76	7.27	10.87	3.94	7.97	-
Current Portion of Leases	0.59	0.29	0.69	1.13	9.89	8.62
Current Unearned Revenue	1.36	1.36	1.36	1.37	2.6	3.02
Other Current Liabilities	9.86	4.72	3.93	4.36	7.55	1.49
Total Current Liabilities	94.4	63.3	53.27	65.21	63.55	40.84
Long-Term Debt	29.97	92.39	92.32	81.71	72.64	19.82
Long-Term Leases	0.56	-	0.29	0.97	0.76	10.65
Other Long-Term Liabilities	-	5	-	-	-	5.05
Total Liabilities	124.93	160.69	145.87	147.9	136.95	76.35
Common Stock	0.02	0.02	0.02	0.17	0.17	0.17
Additional Paid-In Capital	1,409	1,393	1,379	1,369	1,354	1,340
Retained Earnings	-1,291	-1,390	-1,408	-1,382	-1,324	-1,306
Comprehensive Income & Other	0.1	0.01	0.01	-0.15	-0.1	-0
Shareholders' Equity	117.61	3.29	-28.64	-13.62	30.37	34.03
Total Liabilities & Equity	242.53	163.98	117.23	134.28	167.33	110.38
Total Debt	60.88	99.95	104.17	87.75	91.27	39.09
Net Cash (Debt)	76.26	-22.63	-47.23	-29.55	33.7	18.24
Net Cash Growth	-	-	-	-	84.77%	-70.47%
Net Cash Per Share	4.17	-1.28	-2.71	-1.73	1.98	1.08
Filing Date Shares Outstanding	18.15	17.86	17.54	17.37	17.17	17
Total Common Shares Outstanding	18.14	17.71	17.48	17.34	17.16	16.93
Working Capital	120.53	71.8	46	50.69	90.91	48.14
Book Value Per Share	6.48	0.19	-1.64	-0.79	1.77	2.01
Tangible Book Value	92.27	-23.81	-42.52	-28.57	30.37	34.03
Tangible Book Value Per Share	5.09	-1.34	-2.43	-1.65	1.77	2.01
Machinery	-	0.28	1.83	9.48	16.04	15.53
Construction In Progress	-	-	-	-	0.69	0.82
Leasehold Improvements	-	-	-	2.11	-	-

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q